CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net income		$ 8.6	$ 23.9
Net income from discontinued operations, net of tax		0.2	27.4
Net income (loss) from continuing operations		8.4	(3.5)
Reconciliation of net income (loss) from continuing operations to net cash flows provided by (used in) operating activities:
Depreciation and amortization		39.9	38.7
Deferred income taxes		(2.4)	(2.0)
Foreign exchange loss (gain)		24.5	(33.0)
Other, net		10.8	75.4
Changes in assets and liabilities, net of acquisitions:
Accounts receivable		(2.6)	2.8
Inventories		(19.0)	(14.3)
Accounts payable		8.9	9.5
Accrued expenses		(6.2)	(67.3)
Prepaid expenses and other current assets		(4.4)	(4.6)
Other assets and liabilities		3.3	(33.7)
Net cash flows provided by (used in) operating activities of continuing operations		61.2	(32.0)
Cash flows from investing activities:
Capital expenditures		(10.5)	(6.7)
Proceeds from Arysta Sale (net of cash $148.7 million)		0.0	4,192.3
Other, net		(5.9)	8.5
Net cash flows (used in) provided by investing activities of continuing operations		(16.4)	4,194.1
Cash flows from financing activities:
Debt proceeds, net of discount		0.0	749.1
Repayments of borrowings		(2.0)	(4,601.0)
Change in lines of credit, net		320.0	95.3
Repurchases of common stock		(33.1)	(433.6)
Payment of financing fees		0.0	(39.5)
Other, net		(1.5)	(10.8)
Net cash flows provided by (used in) financing activities of continuing operations		283.4	(4,240.5)
Cash flows from discontinued operations:
Net cash flows used in operating activities of discontinued operations		(14.7)	(115.9)
Net cash flows used in investing activities of discontinued operations		0.0	(5.0)
Net cash flows provided by financing activities of discontinued operations		0.0	4.8
Net cash flows used in discontinued operations		(14.7)	(116.1)
Effect of exchange rate changes on cash, cash equivalents and restricted cash		(6.2)	9.4
Net increase (decrease) in cash, cash equivalents and restricted cash		307.3	(185.1)
Cash, cash equivalents and restricted cash at beginning of period	[1]	190.1	415.5
Cash, cash equivalents and restricted cash at end of period		$ 497.4	$ 230.4

[1] Includes cash, cash equivalents and restricted cash of discontinued operations of $0.0 million and $181.9 million at December 31, 2019 and 2018, respectively.